R (British American Tobacco UK Limited & Ors) v Secretary of State for Health19 May 2016In R (British American Tobacco UK Limited & Ors) v Secretary of State for Health, the High Court was asked to consider the lawfulness of the Standardised Packaging of Tobacco Products Regulations 2015. Similar measures were adopted in Australia in 2011. The tobacco company claimants relied upon 15 grounds of challenge. The grounds included proportionality, […]
GlaxoSmithKline UK Limited-and-Wyeth Holdings LLC [2016] EWHC 1045 (CH)12 May 2016Michael Tappin QC and William Duncan appeared for the successful patentee in this claim for revocation by GSK and counterclaim for infringement by Wyeth. The patent related to meningitis B vaccines, identifying a valuable new vaccine candidate now known as factor H binding protein, that forms part of GSK’s Bexsero vaccine. The attacks against the […]
Saertex France -and-Hexcel Reinforcements UK Limited [2016] EWHC 966 (IPEC)4 May 2016Henry Ward, instructed by Gowling WLG (UK) LLP, recently appeared for the defendant in this trial concerning European Patent (UK) No. 1 781 455 B1 entitled ‘Method for making a reinforcement provided with at least one adhesive surface capable of being repositioned and resulting reinforcement’ owned by Saertex France. Saertex claimed infringement of the patent. […]
Unwired Planet International Ltd v Huawei Technologies Ltd, Samsung Electronics Co Ltd and others [2016] EWHC 576 (Pat)22 March 2016Adrian Speck QC, Mark Chacksfield and Tom Jones (instructed by EIP legal) recently appeared for Unwired Planet in the third of four technical trials (Trial C) concerning alleged infringement of patents held by Unwired Planet and said to be essential to various mobile telecommunications standards. The trial concerned the alleged infringement of patent EP (UK) […]
Actavis UK Ltd and others v Eli Lilly & Company [2016] EWHC 234 (Pat) 12 February 201612 February 2016Richard Meade QC and Isabel Jamal, together with Thomas Raphael QC, successfully represented Actavis in the trial of the issues remitted by the Court of Appeal in Actavis v Lilly [2015] EWCA Civ 555. This action concerns Lilly’s European Patent No. 1 313 508 for the use of pemetrexed disodium, a chemotherapeutic treatment for lung […]